Veracyte to Release Q1 2026 Earnings on May 5

Cancer diagnostics company Veracyte will host a conference call to discuss financial results and provide a business update.

Apr. 14, 2026 at 8:36pm

Got story updates? Submit your updates here. ›

An abstract illustration featuring muted geometric shapes and lines in shades of blue, gray, and green, representing the advanced analytics and bioinformatics powering Veracyte's cancer diagnostics business.Veracyte's upcoming earnings report will shed light on the company's progress in leveraging data and technology to advance cancer diagnostics.South San Francisco Today

Veracyte, Inc., a leading cancer diagnostics company, announced that it will release its financial results for the first quarter of 2026 after the market close on Tuesday, May 5, 2026. The company will host a conference call and webcast to discuss the results and provide a general business update at 4:30 p.m. Eastern Time on the same day.

Why it matters

As a major player in the cancer diagnostics market, Veracyte's quarterly earnings and business updates are closely watched by investors and industry analysts to gauge the company's performance and growth prospects.

The details

Veracyte will release its Q1 2026 financial results after the market close on May 5, 2026. The company will then host a conference call and webcast at 4:30 p.m. Eastern Time on the same day to discuss the results and provide a general business update. The webcast will be available on the company's website, and a replay will be accessible following the live broadcast.

  • Veracyte will release Q1 2026 financial results after market close on May 5, 2026.
  • Veracyte will host a conference call and webcast at 4:30 p.m. Eastern Time on May 5, 2026 to discuss the results.

The players

Veracyte, Inc.

A leading cancer diagnostics company that develops and commercializes high-performing cancer tests fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine.

Got photos? Submit your photos here. ›

The takeaway

Veracyte's upcoming Q1 2026 earnings release and conference call will provide investors and analysts with important insights into the company's performance and growth trajectory in the cancer diagnostics market.